non-small cell lung cancer (NSCLC), colorectal cancer (CRC)
Conditions
Interventions
Index test:AmoyDx 
Panel 
Sponsors
Beijing Chest Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) All men and women are 18 or older; 2) Patients with histopathologically confirmed NSCLC are not limited in clinical or pathological stage, and the advanced stage (STAGE IIIb IV) is preferred; 3) NGS test results showed about 100 EGFR 20INS negative samples and about 10~15 positive samples. 4) Can provide enough FFPE tissues:6 piece of tissue,and 5µµm sections with a thickness of 0.5~1cm2 (10 sections if the tissue area is less than 0.5cm2), the sample shall be stored for no more than 18 months, and the tumor cell content shall be no less than 20%.
Exclusion criteria
Exclusion criteria: 1) The tissue samples were pathologically assessed as having too few tumor cells; 2) Tissue samples are contaminated; 3) Other conditions that the investigator considers inappropriate to participate in this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EGFR 20 insertion mutation;consistency; | — |
Countries
China
Contacts
Public ContactNanying Che
Beijing Chest Hospital, Capital Medical University
Outcome results
None listed